MONROVIA, Calif. (AP) — MONROVIA, Calif. (AP) — Xencor Inc. (XNCR) on Thursday reported a loss of $12 million in its fourth quarter.
The Monrovia, California-based company said it had a loss of 20 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 83 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $21.6 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $19.9 million.
For the year, the company reported a loss of $55.2 million, or 93 cents per share. Revenue was reported as $164.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a XNCR">Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR